CN103687859B - 高三尖杉酯碱的胺化衍生物、及其制备方法和应用 - Google Patents

高三尖杉酯碱的胺化衍生物、及其制备方法和应用 Download PDF

Info

Publication number
CN103687859B
CN103687859B CN201280027457.0A CN201280027457A CN103687859B CN 103687859 B CN103687859 B CN 103687859B CN 201280027457 A CN201280027457 A CN 201280027457A CN 103687859 B CN103687859 B CN 103687859B
Authority
CN
China
Prior art keywords
homoharringtonine
cancer
pharmaceutically acceptable
derivative
aminated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201280027457.0A
Other languages
English (en)
Chinese (zh)
Other versions
CN103687859A (zh
Inventor
荣风光
徐荣臻
谢福文
赖洪喜
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hangzhou Bensheng Pharmaceutical Co Ltd
Original Assignee
Hangzhou Bensheng Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hangzhou Bensheng Pharmaceutical Co Ltd filed Critical Hangzhou Bensheng Pharmaceutical Co Ltd
Priority to CN201280027457.0A priority Critical patent/CN103687859B/zh
Publication of CN103687859A publication Critical patent/CN103687859A/zh
Application granted granted Critical
Publication of CN103687859B publication Critical patent/CN103687859B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/12—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
    • C07D493/16—Peri-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/20—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CN201280027457.0A 2011-08-18 2012-08-20 高三尖杉酯碱的胺化衍生物、及其制备方法和应用 Expired - Fee Related CN103687859B (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201280027457.0A CN103687859B (zh) 2011-08-18 2012-08-20 高三尖杉酯碱的胺化衍生物、及其制备方法和应用

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CN2011078586 2011-08-18
CNPCT/CN2011/078586 2011-08-18
PCT/CN2012/080349 WO2013023620A1 (zh) 2011-08-18 2012-08-20 高三尖杉酯碱的胺化衍生物、及其制备方法和应用
CN201280027457.0A CN103687859B (zh) 2011-08-18 2012-08-20 高三尖杉酯碱的胺化衍生物、及其制备方法和应用

Publications (2)

Publication Number Publication Date
CN103687859A CN103687859A (zh) 2014-03-26
CN103687859B true CN103687859B (zh) 2016-08-17

Family

ID=47714778

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201280027457.0A Expired - Fee Related CN103687859B (zh) 2011-08-18 2012-08-20 高三尖杉酯碱的胺化衍生物、及其制备方法和应用

Country Status (5)

Country Link
US (1) US9676789B2 (cg-RX-API-DMAC7.html)
EP (1) EP2746286A4 (cg-RX-API-DMAC7.html)
JP (1) JP6068472B2 (cg-RX-API-DMAC7.html)
CN (1) CN103687859B (cg-RX-API-DMAC7.html)
WO (1) WO2013023620A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020264480A1 (en) * 2019-06-28 2020-12-30 The Johns Hopkins University Compositions and methods of treating liver cancers
CN112704679B (zh) * 2019-10-24 2023-06-06 沈阳药科大学 含高三尖杉酯碱的药物组合物及其应用
KR20220050607A (ko) * 2020-10-16 2022-04-25 국립암센터 개비자 추출물로부터 분리된 화합물을 유효성분으로 포함하는 폐암 예방 또는 치료용 조성물
TW202421631A (zh) * 2022-09-22 2024-06-01 南開大學 三尖杉酯鹼類衍生物及其藥物組合物、製備方法和用途

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1300289A (zh) * 1998-03-20 2001-06-20 肿瘤药物公司 新的三尖杉烷衍生物及其制备方法
CN1474821A (zh) * 2000-10-17 2004-02-11 ����˹��ҩ�﹫˾ 新型粗榧生物碱、其制备方法和其在治疗癌症、白血病、包括耐受通常的化学治疗剂的寄生物在内的寄生物及作为反向治疗剂的应用
CN1660848A (zh) * 2004-02-27 2005-08-31 中国科学院华南植物园 三尖杉酯类生物碱防治植物线虫病害的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020128258A1 (en) * 2001-03-09 2002-09-12 Jean-Pierre Robin Therapeutical method involving subcutaneous administration of drugs containing cephalotaxine derivatives
WO2009148654A2 (en) 2008-03-03 2009-12-10 Sloan-Kettering Institute For Cancer Research Cephalotaxus esters, methods of synthesis, and uses thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1300289A (zh) * 1998-03-20 2001-06-20 肿瘤药物公司 新的三尖杉烷衍生物及其制备方法
CN1474821A (zh) * 2000-10-17 2004-02-11 ����˹��ҩ�﹫˾ 新型粗榧生物碱、其制备方法和其在治疗癌症、白血病、包括耐受通常的化学治疗剂的寄生物在内的寄生物及作为反向治疗剂的应用
CN1660848A (zh) * 2004-02-27 2005-08-31 中国科学院华南植物园 三尖杉酯类生物碱防治植物线虫病害的应用

Also Published As

Publication number Publication date
WO2013023620A1 (zh) 2013-02-21
JP2014521730A (ja) 2014-08-28
EP2746286A4 (en) 2015-01-07
US20140206669A1 (en) 2014-07-24
CN103687859A (zh) 2014-03-26
US9676789B2 (en) 2017-06-13
EP2746286A1 (en) 2014-06-25
JP6068472B2 (ja) 2017-01-25

Similar Documents

Publication Publication Date Title
CN104039794B (zh) 7‑位取代的汉防己乙素衍生物、及其制备方法和应用
CN103946231B (zh) 齐墩果酸酰胺化衍生物、及其制备方法和应用
JP6286365B2 (ja) 1−オキソ/アシル化−14−アシル化オリドニン誘導体、その調製方法及び適用
CN102712654B (zh) 杂环氨基小檗胺衍生物、其制备方法和应用
JP5976810B2 (ja) 5−置換テトランドリン誘導体、その調製方法及びその使用
JP6068472B2 (ja) アミノ化ホモハリントニン誘導体、その調製方法及び使用
CN104334571B (zh) 重楼皂苷i的酰化衍生物、及其制备方法和应用
CN112125914B (zh) 5-取代的小檗胺衍生物,其制备方法和应用
CN103958490B (zh) 2-位烷基或芳香基取代的丹参酮衍生物、及其制备方法和应用
CN102712655B (zh) 小檗胺的二酰亚胺化衍生物、其制备方法和应用
CN105985349A (zh) 七元环小檗碱类似物及其药物组合物、制备方法和用途
CN103635476B (zh) 高三尖杉酯碱的酰化衍生物、及其制备方法和应用
CN103896824B (zh) 脱氢枞酸吲哚衍生物、制备方法及其用途
CN109232710B (zh) 一类特殊的异甾体生物碱及其衍生物的制备方法

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20160817